208 related articles for article (PubMed ID: 32754788)
1. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
[No Abstract] [Full Text] [Related]
4. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.
Muir J; Aronson M; Esplen MJ; Pollett A; Swallow CJ
J Gastrointest Surg; 2016 Dec; 20(12):1950-1958. PubMed ID: 27752808
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
8. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
Kumar S; Long JM; Ginsberg GG; Katona BW
World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
[TBL] [Abstract][Full Text] [Related]
9. The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC).
Hallowell N; Lawton J; Badger S; Richardson S; Hardwick RH; Caldas C; Fitzgerald RC
J Genet Couns; 2017 Aug; 26(4):752-762. PubMed ID: 27837291
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.
Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; Rios E; Pinheiro J; Pinto-Ribeiro I; Ferreira RM; Preto J; Santos-Antunes J; Marques M; Campos M; Almeida F; Espinheira MDC; Amil Dias J; Figueiredo C; Oliveira C; Trindade E; Carneiro F
Gastrointest Endosc; 2018 Jun; 87(6):1566-1575. PubMed ID: 29454568
[TBL] [Abstract][Full Text] [Related]
11. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.
Laszkowska M; Silver ER; Schrope B; Kastrinos F; Wang TC; Hur C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):822-829.e4. PubMed ID: 31220641
[TBL] [Abstract][Full Text] [Related]
12. CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'.
Liu Y; Calzone K; Fasaye GA; Quillin J
J Genet Couns; 2021 Aug; 30(4):1091-1104. PubMed ID: 33655597
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers.
Bryant MK; Sillcox R; Grady WM; Oelschlager BK
Surg Endosc; 2023 Dec; 37(12):9373-9380. PubMed ID: 37644154
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
van der Kaaij RT; van Kessel JP; van Dieren JM; Snaebjornsson P; Balagué O; van Coevorden F; van der Kolk LE; Sikorska K; Cats A; van Sandick JW
Br J Surg; 2018 Jan; 105(2):e176-e182. PubMed ID: 29341148
[TBL] [Abstract][Full Text] [Related]
16. Decision-making and regret in patients with germline
Gamble LA; Grant RRC; Samaranayake SG; Fasaye GA; Koh C; Korman L; Asif B; Heller T; Hernandez JM; Blakely AM; Davis JL
J Med Genet; 2023 Mar; 60(3):241-246. PubMed ID: 35817563
[TBL] [Abstract][Full Text] [Related]
17. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P
Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290
[TBL] [Abstract][Full Text] [Related]
18. Young people's experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management.
Hoskins C; Tutty E; Purvis R; Shanahan M; Boussioutas A; Forrest L
J Genet Couns; 2022 Feb; 31(1):242-251. PubMed ID: 34265132
[TBL] [Abstract][Full Text] [Related]
19. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
Cisco RM; Ford JM; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
[TBL] [Abstract][Full Text] [Related]
20. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.
DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD
J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]